These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 8233444)

  • 21. Diagnostic utility of serum GH, IGF-1 and IGFBP3 in patients of acromegaly with uncontrolled diabetes: a pilot study.
    Dutta P; Singhal S; Sachdeva NK; Shah VN; Pathak A; Mukherjee KK; Bhansali A
    J Assoc Physicians India; 2014 Aug; 62(8):686-90. PubMed ID: 25856936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: experience with a new competitive enzyme immunoassay.
    Kratzsch J; Blum WF; Schenker E; Keller E; Jahreis G; Haustein B; Ventz M; Rotzsch W
    Exp Clin Endocrinol; 1993; 101(3):144-9. PubMed ID: 8223982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acromegaly and serum insulin-like growth factor I.
    Thorner MO
    Horm Res; 2004; 62 Suppl 1():34-6. PubMed ID: 15761230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and endocrine testing in acromegaly.
    Chang-DeMoranville BM; Jackson IM
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):649-68. PubMed ID: 1521517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly.
    Dobrashian RD; O'Halloran DJ; Hunt A; Beardwell CG; Shalet SM
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):589-93. PubMed ID: 8334745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatomedin-C in active and successfully treated acromegaly.
    Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
    Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acromegaly and insulin-like growth factors].
    Zapf J; Froesch ER
    Schweiz Med Wochenschr; 1986 Jan; 116(3):71-7. PubMed ID: 3945791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone (GH) secretory dynamics in a case of acromegalic gigantism associated with hyperprolactinemia: nonpulsatile secretion of GH may induce elevated insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels.
    Yoshida T; Shimatsu A; Sakane N; Hizuka N; Horikawa R; Tanaka T
    J Clin Endocrinol Metab; 1996 Jan; 81(1):310-3. PubMed ID: 8550769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical laboratory indices in the treatment of acromegaly.
    Clemmons DR
    Clin Chim Acta; 2011 Feb; 412(5-6):403-9. PubMed ID: 21075098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acromegalic gigantism with low serum level of growth hormone and elevated serum insulin-like growth factor-I.
    Miyazaki R; Yoshida T; Sakane N; Yasuda T; Umekawa T; Kondo M; Shimatsu A; Hizuka N; Sano T
    Intern Med; 1995 Mar; 34(3):183-7. PubMed ID: 7787324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of serum somatomedin C level to assess the disease activity in patients with acromegaly].
    Liu R; Shi YF; Deng JY
    Zhonghua Nei Ke Za Zhi; 1992 Oct; 31(10):636-8, 659. PubMed ID: 1306459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1.
    Parfitt VJ; Flanagan D; Wood P; Leatherdale BA
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):647-52. PubMed ID: 10197081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal insulin-like growth factor-I in an elderly woman with acromegaly and medical illness.
    Jaffe LS; Rosen HN
    Arch Intern Med; 1994 Jul; 154(13):1533-5. PubMed ID: 8018009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis in acromegaly. Insulin-like growth factor as a parameter of activity].
    Schatz H; Stracke H; Zapf J
    Dtsch Med Wochenschr; 1983 Sep; 108(37):1391-5. PubMed ID: 6349961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical markers of acromegalic activity.
    Jasper H; Chervin A; Vitale M; Mella A; Ropelato G; Basso A
    Medicina (B Aires); 1994; 54(1):25-30. PubMed ID: 7990682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH.
    Daughaday WH; Starkey RH; Saltman S; Gavin JR; Mills-Dunlap B; Heath-Monnig E
    J Clin Endocrinol Metab; 1987 Oct; 65(4):617-23. PubMed ID: 3654910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion.
    Bates AS; Evans AJ; Jones P; Clayton RN
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):417-23. PubMed ID: 7750196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of acromegaly: state of the art.
    Kannan S; Kennedy L
    Expert Opin Med Diagn; 2013 Sep; 7(5):443-53. PubMed ID: 23971897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin secretion and insulin-like growth factor-I levels in active and controlled acromegaly.
    Hopkins KD; Holdaway IM
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):53-7. PubMed ID: 1559300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum IGF-I and IGFBP-3 levels for the assessment of disease activity of acromegaly.
    Chen HS; Lin HD
    J Endocrinol Invest; 1999 Feb; 22(2):98-103. PubMed ID: 10195375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.